|
1
|
Kufer TA, Silljé HH, Körner R, Gruss OJ,
Meraldi P and Nigg EA: Human TPX2 is required for targeting
Aurora-A kinase to the spindle. J Cell Biol. 158:617–623. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ma Y, Lin D, Sun W, et al: Expression of
targeting protein for xklp2 associated with both malignant
transformation of respiratory epithelium and progression of
squamous cell lung cancer. Clin Cancer Res. 12:1121–1127. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mohsenifar J, Almassi-Aghdam M,
Mohammad-Taheri Z, et al: Prognostic values of proliferative
markers ki-67 and repp86 in breast cancer. Arch Iran Med. 10:27–31.
2007.PubMed/NCBI
|
|
4
|
Shigeishi H, Ohta K, Hiraoka M, et al:
Expression of TPX2 in salivary gland carcinomas. Oncol Rep.
21:341–344. 2009.PubMed/NCBI
|
|
5
|
Aguirre-Portolés C, Bird AW, Hyman A,
Cañamero M, Pérez de Castro I and Malumbres M: Tpx2 controls
spindle integrity, genome stability, and tumor development. Cancer
Res. 72:1518–1528. 2012.PubMed/NCBI
|
|
6
|
Zhang L, Huang H, Deng L, et al: TPX2 in
malignantly transformed human bronchial epithelial cells by
anti-benzo[a]pyrene-7,8-diol-9,10-epoxide. Toxicology. 252:49–55.
2008.PubMed/NCBI
|
|
7
|
Li L, Yang G, Ren C, et al: Glioma
pathogenesis-related protein 1 induces prostate cancer cell death
through Hsc70-mediated suppression of AURKA and TPX2. Mol Oncol.
7:484–496. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chang H, Wang J, Tian Y, Xu J, Gou X and
Cheng J: The TPX2 gene is a promising diagnostic and therapeutic
target for cervical cancer. Oncol Rep. 27:353–1359. 2012.PubMed/NCBI
|
|
9
|
Gruss OJ and Vernos I: The mechanism of
spindle assembly: functions of Ran and its target TPX2. J Cell
Biol. 166:949–955. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gruss OJ, Carazo-Salas RE, Schatz CA, et
al: Ran induces spindle assembly by reversing the inhibitory effect
of importin alpha on TPX2 activity. Cell. 104:83–93. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bayliss R, Sardon T, Ebert J, Lindner D,
Vernos I and Conti E: Determinants for Aurora-A activation and
Aurora-B discrimination by TPX2. Cell Cycl. 3:404–407.
2004.PubMed/NCBI
|
|
12
|
Tonon G, Wong KK, Maulik G, et al:
High-resolution genomic profiles of human lung cancer. Proc Natl
Acad Sci USA. 102:9625–9630. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Scharer CD, Laycock N, Osunkoya AO, et al:
Aurora kinase inhibitors synergize with paclitaxel to induce
apoptosis in ovarian cancer cells. J Transl Med. 6:792008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Warner SL, Stephens BJ, Nwokenkwo S, et
al: Validation of TPX2 as a potential therapeutic target in
pancreatic cancer cells. Clin Cancer Res. 15:6519–6528. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stuart JE, Lusis EA, Scheck AC, et al:
Identification of gene markers associated with aggressive
meningioma by filtering across multiple sets of gene expression
arrays. J Neuropathol Exp Neurol. 70:1–12. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li B, Qi XQ, Chen X, et al: Expression of
targeting protein for Xenopus kinesin-like protein 2 is associated
with progression of human malignant astrocytoma. Brain Res.
1352:200–207. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brizova H, Kalinova M, Krskova L, Mrhalova
M and Kodet R: A novel quantitative PCR of proliferation markers
(Ki-67, topoisomerase IIalpha, and TPX2): an immunohistochemical
correlation, testing, and optimizing for mantle cell lymphoma.
Virchows Arch. 456:671–679. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Satow R, Shitashige M, Kanai Y, et al:
Combined functional genome survey of therapeutic targets for
hepatocellular carcinoma. Clin Cancer Res. 16:2518–2528. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shigeishi H, Fujimoto S, Hiraoka M, et al:
Overexpression of the receptor for hyaluronan-mediated motility,
correlates with expression of microtubule-associated protein in
human oral squamous cell carcinomas. Int J Oncol. 34:1565–1571.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Smith LT, Mayerson J, Nowak NJ, et al:
20q11.1 amplification in giant-cell tumor of bone: Array CGH, FISH,
and association with outcome. Genes Chromosomes Cancer. 45:957–966.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei P, Zhang N, Xu Y, et al: TPX2 is a
novel prognostic marker for the growth and metastasis of colon
cancer. J Transl Med. 11:3132013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Morgan-Lappe SE, Tucker LA, Huang X, et
al: Identification of Ras-related nuclear protein, targeting
protein for xenopus kinesin-like protein 2, and stearoyl-CoA
desaturase 1 as promising cancer targets from an RNAi-based screen.
Cancer Res. 67:4390–4398. 2007. View Article : Google Scholar : PubMed/NCBI
|
